Data / Form D filings / Summit Biosciences Inc.
Summit Biosciences Inc.: Form D filing
Summit Biosciences Inc., a pharmaceuticals company in Lexington, KY, filed a Form D with the SEC in 2013. The latest, on May 2, 2013, reports an offering of $750,000 with nothing sold yet.
Find out what Summit Biosciences Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1513 BULL LEA ROAD, Lexington, KY, 40511
- Phone
- (859) 254-0180
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2009
- Revenue range
- $1,000,001 - $5,000,000
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1575898
The full lists. Form D filings in Kentucky: 216 rows, $10.80, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 2, 2013 | New notice | $750,000 | $0 | $750,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Richard A. Cohen | Director | |
| Charles A. Moyer | Director | |
| Sonia L. Egbert | Executive Officer | |
| William A. Lomicka | Director | |
| Edwin A. Cohen | Executive Officer, Director | |
| Greg Plucinski | Executive Officer | |
| Robert A. Saunders | Director |
Every Form D from the week of Apr 29, 2013 · All recent filings in Kentucky · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Summit Biosciences Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.